Works matching AU Maita, Shinya

Results: 21
    1

    Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer.

    Published in:
    International Journal of Clinical Oncology, 2012, v. 17, n. 3, p. 204, doi. 10.1007/s10147-011-0275-6
    By:
    • Narita, Shintaro;
    • Tsuchiya, Norihiko;
    • Yuasa, Takeshi;
    • Maita, Shinya;
    • Obara, Takashi;
    • Numakura, Kazuyuki;
    • Tsuruta, Hiroshi;
    • Saito, Mitsuru;
    • Inoue, Takamitsu;
    • Horikawa, Yohei;
    • Satoh, Shigeru;
    • Habuchi, Tomonori
    Publication type:
    Article
    2
    3
    4

    Real-world survival outcomes of adding docetaxel or abiraterone in patients with high-volume metastatic castration-sensitive prostate cancer: historically controlled, propensity score matched comparison with androgen deprivation therapy.

    Published in:
    World Journal of Urology, 2022, v. 40, n. 5, p. 1135, doi. 10.1007/s00345-022-03963-y
    By:
    • Narita, Shintaro;
    • Kimura, Takahiro;
    • Hatakeyama, Shingo;
    • Hata, Kenichi;
    • Yanagisawa, Takafumi;
    • Maita, Shinya;
    • Chiba, Shuji;
    • Sato, Hiromi;
    • Kashima, Soki;
    • Koizumi, Atsushi;
    • Yamamoto, Ryohei;
    • Takayama, Koichiro;
    • Okane, Katsumi;
    • Ishida, Toshiya;
    • Horikawa, Yohei;
    • Kumazawa, Teruaki;
    • Shimoda, Jiro;
    • Suzuki, Takehiro;
    • Ohyama, Chikara;
    • Egawa, Shin
    Publication type:
    Article
    5
    6
    7
    8

    Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer

    Published in:
    World Journal of Surgical Oncology, 2012, v. 10, n. 1, p. 1, doi. 10.1186/1477-7819-10-1
    By:
    • Narita, Shintaro;
    • Tsuchiya, Norihiko;
    • Kumazawa, Teruaki;
    • Maita, Shinya;
    • Numakura, Kazuyuki;
    • Obara, Takashi;
    • Tsuruta, Hiroshi;
    • Saito, Mitsuru;
    • Inoue, Takamitsu;
    • Horikawa, Yohei;
    • Satoh, Shigeru;
    • Nanjyo, Hiroshi;
    • Habuchi, Tomonori
    Publication type:
    Article
    9
    10
    11
    12

    Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxel.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1477, doi. 10.1007/s10147-022-02203-y
    By:
    • Narita, Shintaro;
    • Kimura, Takahiro;
    • Hatakeyama, Shingo;
    • Hata, Kenichi;
    • Yanagisawa, Takafumi;
    • Maita, Shinya;
    • Chiba, Shuji;
    • Sato, Hiromi;
    • Kashima, Soki;
    • Koizumi, Atsushi;
    • Yamamoto, Ryohei;
    • Takayama, Koichiro;
    • Okane, Katsumi;
    • Ishida, Toshiya;
    • Horikawa, Yohei;
    • Kumazawa, Teruaki;
    • Shimoda, Jiro;
    • Suzuki, Takehiro;
    • Ohyama, Chikara;
    • Egawa, Shin
    Publication type:
    Article
    13
    14

    PRIMARY RETROPERITONEAL CARCINOID TUMOR ASSOCIATED WITH MULTIPLE ENDCRINE NEOPLASIA (MEN) TYPE 1: A CASE REPORT.

    Published in:
    Japanese Journal of Urology / Nihon Hinyokika Gakkai Zasshi, 2011, v. 102, n. 6, p. 735, doi. 10.5980/jpnjurol.102.735
    By:
    • Syuji Chiba;
    • Kazuyuki Numakura;
    • Kiyofumi Satoyoshi;
    • Mitsuru Saito;
    • Yohei Horikawa;
    • Koichiro Takayama;
    • Taketoshi Nara;
    • Sohei Kanda;
    • Yoshiko Miura;
    • Shinya Maita;
    • Hiroshi Tsuruta;
    • Takashi Obara;
    • Teruaki Kumazawa;
    • Shintaro Narita;
    • Norihiko Tsuchiya;
    • Shigeru Satoh;
    • Tomonori Habuchi
    Publication type:
    Article
    15

    Comparison of outcomes in kidney transplantations involving blood-related and non-blood-related living donors: a multicenter retrospective study by the Michinoku renal transplant network.

    Published in:
    Renal Replacement Therapy, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s41100-024-00556-w
    By:
    • Matsuura, Tomohiko;
    • Toyoshima, Moe;
    • Saitoh, Mitsuru;
    • Nishida, Hayato;
    • Hatakeyama, Shingo;
    • Maita, Shinya;
    • Murakami, Reiichi;
    • Sugimura, Jun;
    • Abe, Takaya;
    • Tomita, Hirofumi;
    • Saitoh, Hisao;
    • Tsuchiya, Norihiko;
    • Ohyama, Chikara;
    • Habuchi, Tomonori;
    • Obara, Wataru
    Publication type:
    Article
    16
    17
    18

    Prognostic model for second progression‐free survival and overall survival in patients with high‐risk metastatic hormone‐sensitive prostate cancer treated with abiraterone acetate and androgen deprivation therapy.

    Published in:
    Prostate, 2025, v. 85, n. 1, p. 73, doi. 10.1002/pros.24802
    By:
    • Narita, Shintaro;
    • Yanagisawa, Takafumi;
    • Hatakeyama, Shingo;
    • Hata, Kenichi;
    • Fujita, Kazutoshi;
    • Ueda, Takashi;
    • Tanaka, Toshikazu;
    • Maita, Shinya;
    • Chiba, Shuji;
    • Sato, Hiromi;
    • Sekine, Yuya;
    • Kobayashi, Mizuki;
    • Kashima, Soki;
    • Yamamoto, Ryohei;
    • Numakura, Kazuyuki;
    • Saito, Mitsuru;
    • Takayama, Koichiro;
    • Okane, Katsumi;
    • Ishida, Toshiya;
    • Horikawa, Yohei
    Publication type:
    Article
    19

    Incidence of postoperative cytomegalovirus and BK-polyoma virus infections and graft loss in ABO-incompatible renal transplant recipients: a multicenter retrospective study.

    Published in:
    International Urology & Nephrology, 2024, v. 56, n. 7, p. 2187, doi. 10.1007/s11255-023-03934-1
    By:
    • Kodama, Hirotake;
    • Hatakeyama, Shingo;
    • Matsuura, Tomohiko;
    • Saito, Mitsuru;
    • Nishida, Hayato;
    • Hamaya, Tomoko;
    • Maita, Shinya;
    • Murakami, Reiichi;
    • Tomita, Hirofumi;
    • Saitoh, Hisao;
    • Tsuchiya, Norihiko;
    • Habuchi, Tomonori;
    • Obara, Wataru;
    • Ohyama, Chikara
    Publication type:
    Article
    20

    Efficacy of valganciclovir prophylaxis in kidney transplant recipients following low-dose rituximab induction therapy: a multicenter retrospective study.

    Published in:
    Clinical & Experimental Nephrology, 2025, v. 29, n. 3, p. 359, doi. 10.1007/s10157-024-02578-4
    By:
    • Takehara, Tomohiro;
    • Nishida, Hayato;
    • Ichikawa, Kazunobu;
    • Nawano, Takaaki;
    • Takai, Satoshi;
    • Fukuhara, Hiroki;
    • Matsuura, Tomohiko;
    • Maita, Shinya;
    • Saito, Mitsuru;
    • Murakami, Reiichi;
    • Hatakeyama, Shingo;
    • Obara, Wataru;
    • Saitoh, Hisao;
    • Ohyama, Chikara;
    • Habuchi, Tomonori;
    • Watanabe, Masafumi;
    • Tsuchiya, Norihiko
    Publication type:
    Article
    21

    Short-term outcomes of risk-adapted upfront docetaxel administration in patients with metastatic hormone-sensitive prostate cancer: a multicenter prospective study in Japan.

    Published in:
    2021
    By:
    • Muto, Yumina;
    • Narita, Shintaro;
    • Hatakeyama, Shingo;
    • Maita, Shinya;
    • Chiba, Shuji;
    • Kubo, Kyohei;
    • Aoyama, Yuu;
    • Ito, Ryuichi;
    • Takahashi, Yoshiko;
    • Takahashi, Shuhei;
    • Nakamura, Kumiko;
    • Honma, Naoko;
    • Sato, Hiromi;
    • Koizumi, Atsushi;
    • Igarashi, Ryoma;
    • Okane, Katsumi;
    • Ishida, Toshiya;
    • Horikawa, Yohei;
    • Kumazawa, Teruaki;
    • Akihama, Susumu
    Publication type:
    journal article